Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 8:9:944769.
doi: 10.3389/fmed.2022.944769. eCollection 2022.

Editorial: Targeting Thyroid Hormone-Dependent Pathways in Proliferative and Degenerative Disorders

Andrea Perra  1 , Michelina Plateroti  2
Affiliations
Editorial

Editorial: Targeting Thyroid Hormone-Dependent Pathways in Proliferative and Degenerative Disorders

Andrea Perra et al. Front Med (Lausanne). .
No abstract available

Keywords: T3 analogs; cell proliferation; liver cancer; neurological disorders; thyroid hormones.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Targeting Thyroid Hormone-Dependent Pathways in Proliferative and Degenerative Disorders

References

    1. Roddy H, Meyer T, Roddie C. Novel cellular therapies for hepatocellular carcinoma. Cancers. (2022) 14:504. 10.3390/cancers14030504 - DOI - PMC - PubMed
    1. Frau C, Loi R, Petrelli A, Perra A, Menegon S, Kowalik MA, et al. . Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats. Hepatology. (2015) 61:249–59. 10.1002/hep.27399 - DOI - PubMed
    1. Mohamad B, Shah V, Onyshchenko M, Elshamy M, Aucejo F, Lopez R, et al. . Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. Hepatol Int. (2016) 10:632–9. 10.1007/s12072-015-9679-0 - DOI - PubMed
    1. Kowalik MA, Puliga E, Cabras L, Sulas P, Petrelli A, Perra A, et al. . Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming. J Hepatol. (2020) 72:1159–69. 10.1016/j.jhep.2019.12.018 - DOI - PubMed
    1. Duntas LH, Brenta G. A renewed focus on the association between thyroid hormones and lipid metabolism. Front Endocrinol. (2018) 9:511. 10.3389/fendo.2018.00511 - DOI - PMC - PubMed

Publication types

LinkOut - more resources